European Sepsis Care Survey

June 11, 2023 updated by: Christian S. Scheer, MD, University Medicine Greifswald
The objective of this survey is to investigate the current state of sepsis care around Europe. The study is aiming at hospital structure, emergency departments, wards, intensive care units and clinical diagnostic and microbiological service.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

1450

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Edegem, Belgium
        • Emergency Department Antwerp University Hospital
      • Ostrava-Poruba, Czechia
        • Department of Anesthesiology and Intensive Care Medicine University Hospital of Ostrava
      • Odense, Denmark
        • Department of Emergency Medicine University of Southern Denmark
      • Helsinki, Finland
        • Perioperative, Intensive Care and Pain Medicine Helsinki University Hospital
      • Garches, France
        • Hopital Raymond Poncare Service de Reanimation Medicale
      • Greifswald, Germany
        • University Medicine Greifswald
      • Athens, Greece
        • 4th Department of Internal Medicine ATTIKON University Hospital
      • Tel Aviv, Israel
        • National Institute for Antibiotic Resistance & Infection Control, Ministry of Health
      • Milan, Italy
        • Ospedale Niguarda Ca' Granda Milano
      • Chișinău, Moldova, Republic of
        • State University of Medicine and Pharmaceutics "Nicolae Testemiţanu"
      • Groningen, Netherlands
        • University Medical Center Groningen
      • Trondheim, Norway
        • St Olavs Hospital
      • Wrocław, Poland
        • Department of Anaesthesiology and Intensive Therapy Wroclaw Medical University
      • Porto, Portugal
        • Universidade do Porto Faculdade de Medicina: Porto
      • Bucharest, Romania
        • "Prof CC Iliescu" Emergency Institute for Cardiovascular Diseases, Bucharest
      • St. Petersburg, Russian Federation
        • Vladimir L. Vanevskii Department of Anaesthesiology and Reanimatology, North-Western State Medical University named after Ilya I. Mechnikov
      • Sabadell, Spain
        • Corporació Sanitària Parc Taulí · critical care center, sabadell hospital, Corporació Sanitaria Universitaria Parc Tauli
      • Lund, Sweden
        • Faculty of Medicine, Department of Clinical Sciences Lund, Division of Infection Medicine, Lund University
      • Ankara, Turkey
        • Hacettepe University, Department of Internal Medicine Sihhiye, Ankara
      • London, United Kingdom
        • King's College London, Guy's and St Thomas' Foundation Hospital, Department of Critical Care, London

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

European hospitals

Description

Inclusion Criteria:

  • Hospitals of all strata

Exclusion Criteria:

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Cross-Sectional

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Questionnaire
Time Frame: 2021
Structure of sepsis care in Europe
2021

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Christian S Scheer, Anesthesiology and Intensive Care Medicine Department, University of Greifswald, Germany
  • Principal Investigator: Adam Linder, European Sepsis Alliance
  • Principal Investigator: Daniela Filipescu, European Sepsis Alliance, European Society of Anaesthesiology and Intensive Care
  • Principal Investigator: Evangelos Giamarellos-Bourboulis, European Sepsis Alliance, European Shock Society
  • Principal Investigator: Evgeny Idelevich, ESCMID/Study Group for Bloodstream Infections, Endocarditis and Sepsis
  • Principal Investigator: Konrad Reinhart, Global Sepsis Alliance
  • Principal Investigator: Matthias Gründling, Quality management project Sepsisdialog
  • Principal Investigator: Ricard Ferrer, European Society of Intensive Care Medicine
  • Principal Investigator: Said Laribi, European Society for Emergency Medicine (EUSEM) Research Network
  • Principal Investigator: Manu Malbrain, International Fluid Academy
  • Principal Investigator: Gabriella Bottari, European Society of Paediatric and Neonatal Intensive Care

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2021

Primary Completion (Actual)

April 30, 2022

Study Completion (Actual)

October 30, 2022

Study Registration Dates

First Submitted

August 31, 2021

First Submitted That Met QC Criteria

September 17, 2021

First Posted (Actual)

September 28, 2021

Study Record Updates

Last Update Posted (Estimated)

June 13, 2023

Last Update Submitted That Met QC Criteria

June 11, 2023

Last Verified

June 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • ESA_Survey01
  • BB 124/21 (Other Identifier: Ethics Committee University Medicine Greifswald)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

This study uses no patient data.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sepsis

3
Subscribe